| Details |
| Disease Name | Multiple Sclerosis, Relapsing-Remitting |
| Nocoding RNA Name | hsa-let-7c |
| Expression Pattern | down-regulated |
| Species | Homo sapiens |
| Detection Methods | qPCR etc. |
| Target | N/A |
| Tissue | blood |
| Treatment | natalizumab |
| PubMed ID | 24852919 |
| Year | 2014 |
| Detail Description | Let-7c and miR-125a-5p showed decreased expression levels after treatment initiation (let-7c RQ: t0=2.9, t6=1.1 and t12=1.2; miR-125a-5p RQ: t0=1.9, t6=0.7 and t12=1.2), while miR-642 exhibited an increased expression level (RQ: t0 =-0.4, t6 =0.5,t12 = 0.6). |
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback
© All right reserved 2016